You are here

Article Text

Article menu

Download PDFPDF

Infectious diseases
Original research
How do migrants living with HIV adhere to the HIV care process in high-income countries? A systematic review
  1. Jeanne Goupil de Bouillé1,
  2. Clément Pascal2,
  3. Baptiste Voyer3,
  4. Jérémy Zeggagh3,
  5. Yousra Kherabi3,
  6. Vincent de Andrade4,
  7. Lou Macaux3,
  8. Héloïse Delagreverie3,
  9. Rémi Gagnayre4,
  10. Olivier Bouchaud3,
  11. Nicolas Vignier3
  1. 1APHP, Bobigny, France
  2. 2CHOG, Saint-Laurent-du-Maroni, France
  3. 3AP-HP, Paris, France
  4. 4Université Sorbonne Paris Nord, Villetaneuse, France
  1. Correspondence to Dr Jeanne Goupil de Bouillé; jeanne.goupil{at}aphp.fr

Abstract

Background In high-income countries (HICs), migrants living with HIV (MLHIV) are more likely than other HIV subpopulations to encounter problems which hamper their adherence to the care process; these include social and administrative insecurity, discrimination and psychological distress.

Objective This systematic review aimed to determine the specific features of adherence to the HIV care process among MLHIV in HIC.

Method Three researchers independently selected studies from a search for papers focusing on empirical studies on MLHIV’s adherence to the care process in HIC, published between 1 January 2010 and 1 November 2024 in the following databases: MEDLINE, Embase, CINAHL, PsycINFO and Google Scholar. The three dimensions evaluated for adherence to the care process were adherence to treatment, retention in care and virological response. HICs were characterised according to the World Bank’s definition.

Results Of 601 studies screened, 69 were included (26 (38%) analysing treatment adherence 44 (64%) 44 (64%) retention in care and 34 (48%) virological response). In 49 (71%) of these studies, MLHIV from sub-Saharan Africa accounted for the majority of persons included. MLHIV were mainly categorised according to their geographical region of origin. Only one study considered the reasons for migration. Of 52 statistically significant associations, only five found that being a migrant (vs being a non-migrant) was associated with a better HIV care process. Moreover, several individual (sociodemographic, clinical and psychological), and structural (care system organisation and political) factors associated with difficulties in adhering to the HIV care process were identified.

Discussion MLHIV living in HIC had poorer adherence to the HIV care process for all three dimensions studied (ie, treatment adherence, retention in care and virological response). Research studies categorise MLHIV according to their geographical origin. However, this type of categorisation does not adequately capture social inequalities in health. To overcome this, studies must instead categorise MLHIV according to various intersecting factors, including, among other things, their reason for migrating, the length of time living in the destination country and violence experienced during their migratory journey.

PROSPERO registration number CRD42021253280.

  • HIV & AIDS
  • Medication Adherence
  • VIROLOGY
  • Follow-Up Studies
  • Patient Care Management

Data availability statement

Data sharing not applicable as no datasets generated and/or analysed for this study.

http://creativecommons.org/licenses/by-nc/4.0/

This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.

https://doi.org/10.1136/bmjopen-2024-093620

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    STRENGTHS AND LIMITATIONS OF THIS STUDY

    • This review provides a complete perspective of three dimensions (treatment adherence, retention in care and virological response) of adherence to the care process.

    • We studied the association between being a migrant living with HIV in high-income country and determinants of impaired and good adherence to the care process.

    • Bias was limited as much as possible by double-screening articles and assessing article quality.

    • Estimates for associations in the results are difficult to interpret because of the large heterogeneity in the reference and migrant groups.

    • This systematic review highlights the need to diversify the categorisation of migrants in research studies on HIV’s adherence to the care process in order to better understand social inequalities in health.

    Introduction

    In 2020, globally, there were an estimated 281 million international migrants, representing 3.6% of the world’s population; this figure is expected to rise in the coming years.1 Migrants are particularly exposed to social and administrative insecurity, discrimination and psychological distress.2 Often, the factors involved are intersectional. For example, a lack of housing and not having a residence permit intersect with greater vulnerability to sexual violence and an increased risk of HIV infection.3 In addition, international migrants may have less access to healthcare and HIV prevention services. Moreover, those with HIV face greater difficulties in adhering to the care process.4–6

    HIV prevalence is higher in low-income countries, especially in sub-Saharan Africa.7 In Europe, the 2022 European Centre for Disease Control and Prevention (ECDC) report showed that 11 103 diagnoses were reported among people originating from outside of the reporting country. People coming from sub-Saharan Africa accounted for an additional 13.9% of diagnoses with known region of origin (2781).8 Migrants living with HIV (MLHIV), therefore, constitute a key HIV population in high-income countries (HICs).3 9 10 The new United Nations AIDS Immuno Deficiency Syndrome Global AIDS Strategy focuses on addressing inequalities that drive the HIV pandemic.11 Accordingly, in order to develop appropriate care, data collection and analysis regarding social inequalities is an essential first step. Research highlights that MLHIV require tailored HIV care because of social vulnerabilities, language barriers and different cultural contexts.12 Although several systematic reviews have looked at barriers and facilitators in the HIV care process for MLHIV living in HIC, all have focused on the issue of HIV screening.13–15 None investigated the specific purpose of the care process or the importance of the sociopolitical setting.

    In this context, we performed a systematic review to determine the specific features of adherence to the HIV care process among MLHIV living in HIC. We defined adherence to the HIV care process in terms of three dimensions: adherence to treatment, retention in care, and, indirectly, virological response. Each of these three dimensions was studied along with its positive and negative counterparts: treatment adherence/non-adherence, retention in care/loss to follow-up, virological suppression/virological failure.

    Method

    In order to be as exhaustive as possible in terms of the existing literature, we carried out a mixed-methods systematic review16 which addressed two related questions:

    PICO question 1:

    1. Do different categories of MLHIV have different levels of adherence to the HIV care process in HIC?

      • Population: People living with HIV in HIC.

      • Comparator: People living with HIV born in HIC (ie, non-migrants).

      • Intervention or exposure: Being a migrant.

      • Outcomes: Adherence to the HIV care process.

    PICO Question 2:

    1. What are the barriers and facilitators to adherence to the HIV care process among MLHIV living in HIC?

      • Population: MLHIV living in HIC.

      • Comparator: None.

      • Intervention or exposure: Adherence to the HIV care process.

      • Outcomes: Barriers and facilitators to adherence to the HIV care process.

    Intervention models for adherence to the HIV care process were not included in the analysis but are detailed in the online supplemental appendix (S1).

    Population

    For the present review, the term migrant was defined as a person born in a country not included as an HIC in our study. We chose to consider articles focusing on MLHIV living in the following HICs: the USA, Canada, all countries in Europe, Australia, Israel and Japan. All are classified as HIC according to the World Bank Definition.17 Our review focused on both documented and undocumented migrants.

    Inclusion criteria

    We included papers on empirical studies focusing on the three dimensions of adherence to HIV care process in MLHIV living in HIC as outlined above (ie, treatment adherence, retention in care and virological response). For the quantitative component, we included cross-sectional studies, longitudinal studies and intervention studies reporting baseline data.

    For the qualitative component, we included studies that used (1) qualitative research designs (eg, ethnography, grounded theory approach), (2) qualitative data collection methods (eg, focus groups, individual interviews, observations) and (3) qualitative data analysis methods (eg, thematic analysis, framework analysis).

    Exclusion criteria

    Commentary and editorial studies, case reports and studies focusing on racial statistics without specifying migratory background, as well as studies exploring child populations, were all excluded. Studies on migrants who had become citizens of their new country of residence were also excluded.

    Study eligibility

    All quantitative and qualitative studies in inpatient and outpatient settings were eligible for inclusion.

    Search strategy

    We performed a search on four peer-reviewed literature databases (MEDLINE, Embase, CINAHL and PsycINFO) through PubMed using the following comprehensive research equation ((“HIV”[MH] OR “HIV”[TIAB]) AND (“Treatment Failure”[MH] OR “Treatment Failure”[TIAB] OR “treatment refusal”[MH] OR “treatment refusal” [TIAB] OR “treatment adherence and compliance” [MH] OR “treatment compliance” [TIAB] OR “treatment adherence” [TIAB] OR “Retention in care” [MH] OR “Retention in care” [TIAB] OR “Treatment outcome” [MH] OR “Treatment outcome” [TIAB] OR “Lost-to follow up” [MH] OR “Lost-to follow up” [TIAB] OR “Continuity of Patient Care”[MH] OR “Continuity of Patient Care” [TIAB]) AND (“transients and migrants”[MH] OR transient* [TIAB] OR migrant*[TIAB] OR “refugee*” [MH] OR “refugee*” [TIAB] OR “emigrants and immigrants » [MH] OR «emigrants »[TIAB] OR “immigrant*” [TIAB] OR « emigration and immigration »[MH] OR “emigration”[TIAB] OR “immigration” [TIAB] OR “asylum seeker*” OR “asylum seeker*"[TIAB])). The research equation was developed in collaboration with specialists in infectious diseases and a documentary researcher from a public health laboratory. Grey literature was explored using Google Scholar in order to minimise loss of relevant resources. The online supplemental appendix provides the complete research equation for the various databases.

    Additional relevant papers, including reviews, were identified by manually searching the reference sections of publications included after full-text screening. Conference abstracts where a full report of the relevant study was available were considered.

    We limited searches to articles in French and English language, as these are the two languages the three evaluators (CP, JGdB and JZ) were most familiar with. Furthermore, in order to find a good balance between studies reflecting the current sociopolitical context and not being too restrictive, we limited our search to studies published between 1 January 2010 and 1 November 2024. The review protocol is registered in PROSPERO, number CRD42021253280.

    Data screening and extraction

    All records were imported into Covidence systematic review software (Veritas Health Innovation) and duplicates were removed. The results are reported according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines for systematic reviews.18 Two researchers (CP and JGdB) screened titles and abstracts independently. Screened references were selected for full-text review if the title or abstract suggested that the document might contain relevant information. One researcher (JGdB) screened 100% of the references. Another (YK) screened 80% of them, while a third (JZ) screened the remaining 20%. Disagreements were resolved by a fourth researcher (NV).

    JGdB used a dedicated form on Covidence to extract the following summary data: study type, place where study was performed, study aim, study definition of a migrant, study population’s administrative status (ie, documented vs undocumented), country of birth, study’s definition of adherence to care process, study period, inclusion criteria and the number of participants. The quality of the studies included was assessed by BV using the validated Mixed Methods Appraisal Tool (MMAT).19

    Data analysis

    Quantitative measures of the association between migration and adherence to care process were assessed by odds ratio (OR), relative risk, hazard ratio (HR) or incidence rate ratio according to the design of the relevant study.

    Our findings are summarised descriptively. Results are presented in forest plots. All analyses were performed using the meta package in R (V.4.1.2).

    Results

    Figure 1 shows the study selection process. 601 unique references were screened based on title and abstract. Inter-reviewer agreement for title and abstract screening was 85%. Inter-rater reliability (Cohen’s κ) was 0.55.

    Figure 1
    Figure 1

    Systematic reviews flow diagram of studies on migration and HIV care pathway.

    Of these 601 references, 511 were excluded because they were off-topic. Accordingly, 90 articles were selected for full-text assessment. Seven articles identified by citation searching were also eligible. After reading the full texts, 70 manuscripts were eligible. Of these, two (one abstract20 and an original article21) focused on the same study and were secondarily excluded. Accordingly, a total of 69 studies were included in the review.

    Table 1 summarises the characteristics of included studies; 59 (86%) used quantitative data, 10 qualitative data (14%), 40 (49%) were conducted in Europe and 49 (71%) included migrants from sub-Saharan Africa. Only 10 (14%) provided information on migrants’ administrative status. Retention in care/loss to follow-up was the main variable studied in terms of adherence to the care process (n=44 (64%)). Only five (7%) studies proposed intervention models to deal with patients lost to follow-up22–26 (online supplemental appendix S1). All 69 studies are presented in online supplemental appendix S2 with the following information: study type, place where study was performed, study aim, study definition of a migrant, study population’s administrative status, place of origin, study’s definition of adherence to care process, study period, inclusion criteria and number of participants. The MMAT study quality assessment is presented in online supplemental appendix S3.

    View this table:
    Table 1

    Description of studies on migration and HIV care pathways included in the systematic review

    Quantitative studies

    Figures 2–5 illustrate adherence and difficulties in the care process among migrants and non-MLHIV in HIC according to several variables and measures of association in the 23 quantitative studies included (figure 2A treatment adherence, figure 2B treatment non-adherence, figure 3A retention in care, figure 3B loss to follow-up, figure 4 virological suppression, figure 5 virological failure). We extracted a total of 89 measures of association. We extracted a total of 89 measures of association. Of these, 52 were statistically significant; more specifically, two out of the three associations found for treatment adherence were significant, as were 3 out of the 12 for non-adherence to treatment, 2 out of 2 for retention in care, 20 out of 32 for loss to follow-up, 13 out of 23 for virological suppression and 12 out of 17 for virological failure.

    Figure 2
    Figure 2

    Adherence (A) and non-adherence (B) to antiretroviral therapy among migrants and non-migrants LWH in the high-income countries (adjusted OR, adjusted incidence ratio (IR), adjusted relative risk (RR) and 95% CI). Figures have been rounded off to the decimal point. *Unadjusted. IR, incidence ratio; LWH, living with HIV; M, men, Mig., migrants; Ref, reference; RR, relative risk; SSA, sub-Saharan Africa; W, women.

    Figure 3
    Figure 3

    Retention in care (A) and lost to follow-up (B) for migrants living in high-income country (adjusted HR, adjusted incidence ratio (IR), adjusted OR, adjusted relative risk (RR)). Figures have been rounded off to the decimal point except for retention in care. EE, Eastern Europe; Immig, immigrants; IR, incidence ratio; LAC, Latin America Caribbean; M, men, NA, Nord Africa; Mig, migrants; NWR, North-Western Region; MSM, men who have sex with men; Ref, reference; SSA, sub-Saharan Africa; SE, Southern Europe; W, women.

    Figure 4
    Figure 4

    HIV virological suppression for migrants and non-migrants LWH in high-income countries (adjusted OR, adjusted HR, adjusted relative risk (RR), 95% CI). Figures have been rounded off to the decimal point. FRA, French natives; LAC, Latin America Caribbean; LMICs, low-income and middle-income countries; LWH, living with HIV; M, men; NAME, North Africa and the Middle East; NFW, non-French West Indies; Mig, migrants; NWR, North-Western Region; MSM, men who have sex with men; Pop., population; Ref., reference; SSA, sub-Saharan Africa; W, women.

    Figure 5
    Figure 5

    HIV virological failure for migrants living in high-income country (adjusted OR, HR, incidence ratio (IR)). *Unadjusted OR. Figures have been rounded off to the decimal point. LMIC, low-income and middle-income countries; M, men; Mig, migrants; M/NM LWH, migrants and non-migrants living with HIV; Ref., reference; SSA, sub-Saharan Africa; W, women.

    Of these 52 statistically significant associations, all but five found an association between migration background and poor adherence to the care process.

    In the 59 quantitative studies included, MLHIV were categorised according to geographical origin in 21, gender in 5, marital status in 2, administrative status in 1 and sexual orientation in 1. In eight studies, the migrant group was studied without further categorisation.

    With regard to geographical origin, MLHIV from sub-Saharan Africa were the population most likely to encounter difficulties in adhering to the HIV care process. Of the 11 significant associations found for sub-Saharan Africa, 10 highlighted difficulties with the 3 dimensions we studied (ie, treatment adherence, retention in care and virological response); the remaining association found less loss to follow-up among these patients in a centre where peer educators were practising.27

    Among all 59 quantitative studies, only one investigated the potential association between migrant administrative status and adherence to the HIV care process and found a positive association for all three studied dimensions. Moreover, only one study looked at the men who have sex with men (MSM) migrant subgroup. Virological suppression (defined as a viral load <500 copies/mL at the last measurement) was less common in this group than among native MSM (adjusted OR 0.23 (95% CI 0.19 to 0.29)).28

    Quantitative and qualitative studies

    Table 2 groups together the 59 quantitative and 10 qualitative studies which identified barriers and facilitators to adherence to the HIV care process among MLHIV in HIC. We classed these barriers and facilitators into five categories as follows: sociodemographic, clinical, psychological, care system organisation and migration policy. Barriers to adherence to the care process were more frequently studied than facilitators.

    View this table:
    Table 2

    Factors associated with adherence to the HIV care process in MLHIV in high-income countries; quantitative and qualitative studies

    Data from the quantitative studies tended to be descriptive, whereas the data from the qualitative studies tended to be explanatory.

    Sociodemographic factors

    In quantitative studies, male gender,20 21 29 30 low socioeconomic status31 and being single32 33 were identified as barriers. In qualitative studies, food insecurity,34 35 stigmatisation34–37 and family rejection34 35 were barriers.

    Only one study studied the reason for migration as a potential determinant; it found that migration for health reasons was a facilitator while migration for economic reasons was a barrier.36

    Clinical factors

    In quantitative studies, a low quality of life score was a barrier while in qualitative studies, the absence of symptoms was a barrier.23 36

    Psychological factors

    Depression and anxiety (barriers) were mainly studied in qualitative studies. Psychological support was a facilitator in qualitative studies.22 34 35 38 38–40

    Healthcare organisation

    Quantitative studies mainly focused on the care pathway,31 while qualitative studies focused on the skills healthcare staff needed to improve adherence.22 26 29 35 36 41 42 Both study designs found that providing culturally sensitive care,22 26 29 implementing actions that foster links between healthcare workers and migrants, and the level of adaptation of the healthcare system to migrants’ characteristics were all facilitators. In particular, the use of community health mediators,35 interpreters,36 bicultural staff29 and bilingual staff41 seemed to be particularly effective.

    Migration and health policies

    Quantitative studies focused solely on the legal status of patients,43 while qualitative studies looked at migrants’ fears of the relevant country’s national immigration and deportation policies,22 34 35 work restrictions,44 difficulties getting paperwork in order44 and migrants’ lack of awareness of their rights and legal status.35 Undocumented status was a barrier in three studies and a facilitator in just one study.

    Access to free treatment was found to be a facilitator for retention in care in one qualitative study.

    Discussion

    Our mixed-methods systematic review provides a general, multidimensional insight into adherence to the HIV care process in MLHIV living in HIC. Globally, we found that most of this population has less than optimal adherence to all three dimensions of the care process we studied (ie, adherence to treatment/non-adherence to treatment, retention in care/lost to follow-up and virological suppression/virological failure).

    84% of the studies we included were quantitative and therefore their results were mainly descriptive. However, adherence to the care process is a complex cognitive-emotional process, and qualitative studies provide a more in-depth exploration of the mechanisms of these processes.45 Future research on adherence to the care process would benefit from using this methodology. No mixed-methods studies were identified, despite the fact that this research approach combines the robustness of quantitative and qualitative studies.46 47 Overall, our results highlight the compartmentalisation of research disciplines.

    Of the 58 quantitative studies included, only 11 looked at all three dimensions. Adherence to treatment was the least studied dimension, but also probably the most difficult to measure. Self-reported questionnaires are subject to social conformity bias, while measuring drug dosages and random pill counts are processes that require a certain logistic complexity.48 Virological response and retention in care are variables that are part of routine care and simpler to collect.

    Studying individual risk factors and categorising migrants

    Our review found that no migrant category was more likely than another to have poor adherence to the HIV care process. The quantitative studies we included primarily classified patients based mainly on geographical origin; however, such a simple categorisation does not take into account different intersecting social and cultural determinants that can influence adherence, including (possibly traumatic) life events during the migratory journey, level of health literacy, educational level, social precariousness, loneliness, administrative insecurity, social representations of the healthcare system and health and living conditions in the host country. All these factors may impact adherence much more than geographical origin. One could hypothesise that these elements could be decisive in the cognitive process of adherence to treatment.36 Migrants are an extremely heterogeneous group, in cultural, social or psychological dimensions, making it difficult to define and categorise them.49 50

    Risk factors at the level of care system organisation and policy

    In the majority of studies (ie, both quantitative and qualitative) included, the evaluation of health interventions was based in the hospital setting; few studies evaluated the impact of migration and health policies on MPHIV’s adherence to the care process. One review identified national policies for delivering tuberculosis, HIV and hepatitis B and C virus infection services for refugees and migrants among member states of the WHO European Region.51 In terms of HIV, only 15 national policy documents and guidelines for refugees were identified. The articles included highlight the considerable heterogeneity in the implementation of policies and recommendations advocated by the WHO and ECDC. In some countries (eg, Angola, Azerbaijan, Israel), migrants must present a negative HIV test result in order to obtain a work permit.52 However, our review found no study examining the impact of this policy on documented or undocumented MLHIV’s adherence to the care process. Our review highlights the importance of assessing the impact of public policies on MLHIV’s health and the need to support the public health facilitators identified at the beginning of our discussion section to compensate for the social inequities experienced by migrants.

    Facilitators for adherence to the HIV care process

    Three quantitative studies (two in the USA and one in France) found that migrants were more likely than non-migrants to adhere to the care process in terms of the virological response and retention in care dimensions.27 31 53 This result merits particular attention. For example, one of the two studies from the USA concerned the Ryan White HIV AIDS programme which provides treatment and related services to people who do not have adequate health insurance. In that study, data from the Centers for Disease Control and Prevention in the USA showed that sustained virological suppression was achieved by 68% of people in the Ryan White HIV AIDS programme, compared with 58% of those not in the programme.54 The French single-site study found similar results, with migrants having better adherence to the care process. This can be explained in part by France’s healthcare policy which guarantees 100% universal access without advance payment for precarious documented and undocumented patients,27 and by the involvement of peer educators. Other studies in France have shown that free healthcare would seem to be a necessary but insufficient criterion for adherence to care in migrants.55–58

    With regard to the second PICO research question, our review identified other facilitators of adherence to the HIV care process in migrants including community health workers,26 35 36 41 home visits,22 the intervention of interpreters,36 41 psychological support for depressive disorders,26 36 59 flexible consultation hours,22 36 free treatment for persons with financial difficulties35 and residence permits.22 34 35

    All these facilitators highlight how healthcare organisations and health policies can tackle the barriers MLHIV face and empower them to become actors in their own care trajectory. Our study advocates the development of patient education, health mediation and psychological support, among other actions, and their integration into health policies. In order to understand adherence to the care process in a research perspective, more studies on little-studied topics—such as migrants’ administrative status, their migratory journey and healthcare interventions—need to be conducted.

    Missing data in the literature and research topics to be developed

    We found that there is a great lack of data on MLHIV’s adherence to the care process in the literature for specific factors including their administrative status, their migration history, their level of literacy, therapeutic education programmes targeting them, tailored interventions carried out by peer educators and evaluations of public health interventions at the individual, hospital and political levels. We look at these different elements in greater detail below.

    Migrants’ administrative status may generate anxiety and consequently impact adherence to HIV treatment.60 Socioeconomic data must be systematically collected for a more holistic approach to care.61 Surprisingly, one study found that having undocumented status was associated with good adherence to the HIV care process for all three adherence dimensions we explored. It was carried out at the Montefiore Medical Center in New York, a clinic funded by the Ryan White HIV AIDS programme, where patients benefit from MEDICAID social security coverage and free treatment through the AIDS Drug Assistance Programme. The authors cited these two measures, fewer drug users in the MLHIV population and the presence of peer educators, to explain this result.62

    Migration history was not examined in any quantitative study, and in only one qualitative study. The latter examined the reason for migration. Migration history is a complex question that covers a number of different parameters including the reason for migration, duration of the migratory journey, the mode of transport taken, physical and sexual violence during the journey and psychotrauma in the broadest sense. All these parameters can impact adherence to the HIV care process, just as premigration psychotrauma has already demonstrated its influence on risky sexual behaviour.63 Taking these different factors into account as part of a holistic approach to treatment adherence seems necessary.

    No study assessed interventions carried out by peer educators, particularly on health education. Furthermore, patients’ level of health literacy was never specified, despite the recognised direct link between health literacy and adherence to the care process.64 A systematic review of health literacy interventions for people living with HIV was conducted and found six articles on literacy interventions for people living with HIV, with no specific reference to the issue of migration.65 The majority of these interventions were designed to improve HIV treatment adherence as well as HIV knowledge and treatment-related skills, with one study focusing on e-Health literacy. In our review, more studies examined the barriers to adherence to the HIV care process than the facilitators. For example, only three studies36 38 39 reported psychological support (a facilitator), whereas psychological vulnerabilities (a barrier) were studied in eight studies.22 23 34 35 38–40 66 Moreover, only five studies evaluated intervention models as their primary objective.22 24 36 44 59 All these results highlight a gap in the scientific validation of public health interventions. Yet such a validation would appear to be the necessary first step in convincing public decision-makers of the importance of these interventions with a view to obtaining funding for them.

    Study strengths and limitations

    To our knowledge, only a small number of other reviews5 14 43 67 have addressed the issue of MLHIV adherence to the care process in HIC. Of these, only one used a systematic review methodology; that review focused on the barriers in the cascade of care. However, it did not address our PICO research question on the categorisation of migrants and its implication in the context of research. By making an exhaustive analysis of three dimensions to adherence to the HIV care process, our review provides a comprehensive picture: it studies both the association between migratory origin and difficulties in the care pathway and highlights the determinants of impaired and better adherence to the HIV care process among MLHIV.

    Our review has several limitations. First, although the screening process for titles and abstracts was carried out by two different people, data and quality assessment of articles were extracted by a single person. Second, in quantitative studies, the duration of migration was not extracted if it was not one of the variables used to categorise migrants. Third, our estimates for associations are difficult to interpret due to the heterogeneity of the reference and migrant groups. Studies on the care pathways of MLHIV are by nature heterogeneous. Indeed, in the literature, the categorisation of migrant groups is mainly determined according to geographical origin (sometimes geographical origin and gender or sexual orientation), something which differs greatly depending on where the studies are carried out: most often South America for studies from the USA, and sub-Saharan Africa for studies in Europe. As mentioned above, there can be significant differences in people with the same geographical origin, and this review is limited by the lack of published work on using a more comprehensive range of determinants than simply geographical origin. Finally, only English and French-language papers were included.

    Conclusions

    MLHIV living in HIC would appear to have poor adherence to the HIV care process (studied here in terms of three dimensions: based on treatment adherence, retention in care and virological response). MLHIV are a heterogeneous group mostly characterised in the literature by their geographical origin. This variable is too general, as it does not distinguish cultural and sociological determinants. In the MLHIV population, many barriers have been identified at the clinical, psychological and socioeconomic levels, as well as in terms of the organisation of the healthcare system and a country’s immigration and health policy. However, many facilitators have also been identified, such as community health mediation, psychological support, the help of interpreters and free access to care. To improve care of MLHIV living in HIC, more studies aiming at understanding patients’ experiences, particularly with regard to a person’s migration history (eg, the reason for migrating, migration-related events) are needed. Moreover, future studies should integrate socioeconomic and cultural determinants, and more concrete assessments of health policies and their applications.

    Data availability statement

    Data sharing not applicable as no datasets generated and/or analysed for this study.

    Ethics statements

    Patient consent for publication

    References

    1. ↵
      1. Sanni O,
      2. Salami B,
      3. Oluwasina F, et al
      . Climate change and African migrant health. Int J Environ Res Public Health 2022;19:16867. doi:10.3390/ijerph192416867
    2. ↵
      World report on the health of refugees and migrants. File:///users/jeannegoupil/downloads/9789240054462-eng.pdf,
    3. ↵
      1. Pannetier J,
      2. Ravalihasy A,
      3. Lydié N, et al
      . Prevalence and circumstances of forced sex and post-migration HIV acquisition in sub-Saharan African migrant women in France: an analysis of the ANRS-PARCOURS retrospective population-based study. Lancet Public Health 2018;3:e16–23. doi:10.1016/S2468-2667(17)30211-6
      OpenUrlPubMed
    4. ↵
      1. Fakoya I,
      2. Álvarez-Del Arco D,
      3. Monge S, et al
      . HIV testing history and access to treatment among migrants living with HIV in Europe. J Int AIDS Soc 2018;21 Suppl 4:e25123. doi:10.1002/jia2.25123
    5. ↵
      1. Tanser F,
      2. Bärnighausen T,
      3. Vandormael A, et al
      . HIV treatment cascade in migrants and mobile populations. Curr Opin HIV AIDS 2015;10:430–8. doi:10.1097/COH.0000000000000192
      OpenUrl
    6. ↵
      1. Thomas R,
      2. Galanakis C,
      3. Vézina S, et al
      . Adherence to Post-Exposure Prophylaxis (PEP) and incidence of HIV seroconversion in a major North American cohort. PLoS ONE 2015;10:e0142534. doi:10.1371/journal.pone.0142534
    7. ↵
      1. World health organization
      . HIV statistics, globally and by WHO region, 2023. Available: https://cdn.who.int/media/docs/default-source/hq-hiv-hepatitis-and-stis-library/j0294-who-hiv-epi-factsheet-v7.pdf
    8. ↵
      1. ECDC, European Centre for Disease Prevention and Control
      . HIV/AIDS surveillance in Europe, Available: https://www.ecdc.europa.eu/sites/default/files/documents/2022-Annual_HIV_Report_final.pdf
    9. ↵
      1. Santoso D,
      2. Asfia SKBM,
      3. Mello MB, et al
      . HIV prevalence ratio of international migrants compared to their native-born counterparts: A systematic review and meta-analysis. EClinicalMedicine 2022;53:101661. doi:10.1016/j.eclinm.2022.101661
    10. ↵
      1. Desgrées-du-Loû A,
      2. Pannetier J,
      3. Ravalihasy A, et al
      . Sub-Saharan African migrants living with HIV acquired after migration, France, ANRS PARCOURS study, 2012 to 2013. Euro Surveill 2015;20. doi:10.2807/1560-7917.ES.2015.20.46.30065
    11. ↵
      1. UNAIDS
      . Global AIDS Strategy 2021-2026 — End Inequalities. End AIDS, Available: https://www.unaids.org/sites/default/files/media_asset/global-AIDS-strategy-2021-2026_en.pdf
    12. ↵
      1. Sen P,
      2. Waterman LZ,
      3. Crowley G, et al
      . Clinicians caring for migrants need more support. BMJ 2022;377:e071007. doi:10.1136/bmj-2022-071007
    13. ↵
      1. Alvarez-del Arco D,
      2. Monge S,
      3. Azcoaga A, et al
      . HIV testing and counselling for migrant populations living in high-income countries: a systematic review. Eur J Public Health 2013;23:1039–45. doi:10.1093/eurpub/cks130
      OpenUrlCrossRefPubMedWeb of Science
    14. ↵
      1. Arora AK,
      2. Ortiz-Paredes D,
      3. Engler K, et al
      . Barriers and facilitators affecting the HIV care cascade for migrant people living with HIV in organization for economic co-operation and development countries: a systematic mixed studies review. AIDS Patient Care STDS 2021;35:288–307. doi:10.1089/apc.2021.0079
      OpenUrl
    15. ↵
      1. Blondell SJ,
      2. Kitter B,
      3. Griffin MP, et al
      . Barriers and facilitators to HIV testing in migrants in high-income countries: a systematic review. AIDS Behav 2015;19:2012–24. doi:10.1007/s10461-015-1095-x
      OpenUrlCrossRefPubMed
    16. ↵
      1. Pluye P,
      2. Hong QN,
      3. Bush PL, et al
      . Opening-up the definition of systematic literature review: the plurality of worldviews, methodologies and methods for reviews and syntheses. J Clin Epidemiol 2016;73:2–5. doi:10.1016/j.jclinepi.2015.08.033
      OpenUrlPubMed
    17. ↵
    18. ↵
      1. Page MJ,
      2. McKenzie JE,
      3. Bossuyt PM, et al
      . The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021;372:n71. doi:10.1136/bmj.n71
    19. ↵
      1. Pluye P,
      2. Hong QN,
      3. Vedel I
      . Toolkit for mixed studies reviews (V3) [and Quebec-SPOR SUPPORT Unit]. Montreal: Department of Family Medicine, McGill University, Available: http://toolkit4mixedstudiesreviews
    20. ↵
      1. Saracino A,
      2. Lorenzini P,
      3. Lo Caputo S, et al
      . Increased risk of virological failure to the first antiretroviral regimen in HIV‐infected migrants compared to natives: data from the ICONA cohort. J Int AIDS Soc 2014;17. doi:10.7448/IAS.17.4.19769
    21. ↵
      1. Saracino A,
      2. Lorenzini P,
      3. Lo Caputo S, et al
      . Increased risk of virologic failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: data from the ICONA cohort. Clin Microbiol Infect 2016;22:288. doi:10.1016/j.cmi.2015.10.026
      OpenUrl
    22. ↵
      1. Arnold EA,
      2. Fuller SM,
      3. Martinez O, et al
      . Documenting best practices for maintaining access to HIV prevention, care and treatment in an era of shifting immigration policy and discourse. PLoS One 2020;15:e0229291. doi:10.1371/journal.pone.0229291
    23. ↵
      1. Been SK,
      2. Yildiz E,
      3. Nieuwkerk PT, et al
      . Self-reported adherence and pharmacy refill adherence are both predictive for an undetectable viral load among HIV-infected migrants receiving cART. PLoS One 2017;12:e0186912. doi:10.1371/journal.pone.0186912
    24. ↵
      1. Elbirt D,
      2. Asher I,
      3. Mahlev-Guri K, et al
      . Direct monthly highly active antiretroviral therapy supply - a method to increase patient’s adherence and outcome. Experience of one AIDS centre in Israel. Int J STD AIDS 2014;25:579–86. doi:10.1177/0956462413515443
      OpenUrlCrossRefPubMed
    25. ↵
      1. Sauceda JA,
      2. Brooks RA,
      3. Xavier J, et al
      . From theory to application: a description of transnationalism in culturally-appropriate HIV interventions of outreach, access, and retention among latino/a populations. J Immigr Minor Health 2019;21:332–45. doi:10.1007/s10903-018-0753-2
      OpenUrl
    26. ↵
      1. Zamudio-Haas S,
      2. Maiorana A,
      3. Gomez LG, et al
      . “No Estas Solo”: navigation programs support engagement in HIV care for mexicans and puerto ricans living in the continental U.S. J Health Care Poor Underserved 2019;30:866–87. doi:10.1353/hpu.2019.0060
      OpenUrl
    27. ↵
      1. Fournier AL,
      2. Yazdanpanah Y,
      3. Verdon R, et al
      . Incidence of and risk factors for medical care interruption in people living with HIV in recent years. PLoS One 2019;14:e0213526. doi:10.1371/journal.pone.0213526
    28. ↵
      1. Helleberg M,
      2. Häggblom A,
      3. Sönnerborg A, et al
      . HIV care in the Swedish-Danish HIV cohort 1995-2010, closing the gaps. PLoS One 2013;8:e72257. doi:10.1371/journal.pone.0072257
    29. ↵
      1. Cyrus E,
      2. Dawson C,
      3. Fennie KP, et al
      . Disparity in retention in care and viral suppression for black caribbean-born immigrants living with HIV in Florida. Int J Environ Res Public Health 2017;14:285. doi:10.3390/ijerph14030285
    30. ↵
      1. Kankou J-M,
      2. Bouchaud O,
      3. Lele N, et al
      . Factors associated with virological rebound in HIV-positive sub-saharan migrants living in France after traveling back to their native country: ANRS-VIHVO 2006-2009 Study. J Immigr Minor Health 2019;21:1342–8. doi:10.1007/s10903-019-00864-y
      OpenUrl
    31. ↵
      1. Sheehan DM,
      2. Cosner C,
      3. Fennie KP, et al
      . Role of country of birth, testing site, and neighborhood characteristics on nonlinkage to HIV care among latinos. AIDS Patient Care STDS 2018;32:165–73. doi:10.1089/apc.2018.0021
      OpenUrl
    32. ↵
      1. Abgrall S,
      2. Fugon L,
      3. Lélé N, et al
      . Visiting one’s native country: the risks of nonadherence in HIV-infected sub-Saharan migrants--ANRS VIHVO study. J Int Assoc Provid AIDS Care 2013;12:407–13. doi:10.1177/2325957413488181
      OpenUrlCrossRefPubMed
    33. ↵
      1. Abgrall S,
      2. Fugon L,
      3. Lélé N, et al
      . Risk factors for adherence failure in HIV-infected sub-Saharan migrants living in France and travelling back to their native country. Int J STD AIDS 2014;25:389–90. doi:10.1177/0956462413506894
      OpenUrlCrossRefPubMed
    34. ↵
      1. Levison JH,
      2. Bogart LM,
      3. Khan IF, et al
      . “Where it falls apart”: barriers to retention in HIV care in Latino immigrants and migrants. AIDS Patient Care STDS 2017;31:394–405. doi:10.1089/apc.2017.0084
      OpenUrlPubMed
    35. ↵
      1. Remien RH,
      2. Bauman LJ,
      3. Mantell JE, et al
      . Barriers and facilitators to engagement of vulnerable populations in HIV primary care in New York City. J Acquir Immune Defic Syndr 2015;69 Suppl 1:S16–24. doi:10.1097/QAI.0000000000000577
      OpenUrl
    36. ↵
      1. Guionnet A,
      2. Navaza B,
      3. Pizarro de la Fuente B, et al
      . Immigrant women living with HIV in Spain: a qualitative approach to encourage medical follow-up. BMC Public Health 2014;14:1115. doi:10.1186/1471-2458-14-1115
    37. ↵
      1. Taylor BS,
      2. Liang Y,
      3. Garduño LS, et al
      . High risk of obesity and weight gain for HIV-infected uninsured minorities. J Acquir Immune Defic Syndr 2014;65:e33–40. doi:10.1097/QAI.0000000000000010
      OpenUrlCrossRefPubMed
    38. ↵
      1. Been SK,
      2. Schadé A,
      3. Bassant N, et al
      . Anxiety, depression and treatment adherence among HIV-infected migrants. AIDS Care 2019;31:979–87. doi:10.1080/09540121.2019.1601676
      OpenUrl
    39. ↵
      1. Ivanova E,
      2. Coroiu A,
      3. Ahluwalia A, et al
      . Preliminary findings on the association between symptoms of depression and adherence to antiretroviral therapy in individuals born inside versus outside of Canada. J Assoc Nurses AIDS Care 2016;27:512–23. doi:10.1016/j.jana.2016.02.005
      OpenUrl
    40. ↵
      1. Arrey AE,
      2. Bilsen J,
      3. Lacor P, et al
      . Perceptions of stigma and discrimination in health care settings towards Sub-Saharan African migrant women living with HIV/AIDS in Belgium: a qualitative study. J Biosoc Sci 2017;49:578–96. doi:10.1017/S0021932016000468
      OpenUrl
    41. ↵
      1. Kinoshita M,
      2. Oka S
      . Migrant patients living with HIV/AIDS in Japan: Review of factors associated with high dropout rate in a leading medical institution in Japan. PLoS One 2018;13:e0205184. doi:10.1371/journal.pone.0205184
    42. ↵
      1. Logie CH,
      2. Kennedy VL,
      3. Tharao W, et al
      . Engagement in and continuity of HIV care among African and Caribbean Black women living with HIV in Ontario, Canada. Int J STD AIDS 2017;28:969–74. doi:10.1177/0956462416683626
      OpenUrl
    43. ↵
      1. Ross J,
      2. Cunningham CO,
      3. Hanna DB
      . HIV outcomes among migrants from low-income and middle-income countries living in high-income countries: a review of recent evidence. Curr Opin Infect Dis 2018;31:25–32. doi:10.1097/QCO.0000000000000415
      OpenUrl
    44. ↵
      1. Dang BN,
      2. Giordano TP,
      3. Kim JH
      . Sociocultural and structural barriers to care among undocumented Latino immigrants with HIV infection. J Immigr Minor Health 2012;14:124–31. doi:10.1007/s10903-011-9542-x
      OpenUrlCrossRefPubMed
    45. ↵
      1. Houston E,
      2. Mindry D,
      3. Alvarado E, et al
      . Hidden cues for approach and avoidance motivation: implicit cognitive associations among patients with Nonadherence to HIV treatment. AIDS Care 2022;34:1257–63. doi:10.1080/09540121.2021.2008296
      OpenUrl
    46. ↵
      1. Camlin CS,
      2. Seeley J
      . Qualitative research on community experiences in large HIV research trials: what have we learned? J Int AIDS Soc 2018;21 Suppl 7:e25173. doi:10.1002/jia2.25173
    47. ↵
      1. Creswell JW,
      2. Plano Clark VL
      . Designing and conducting mixed methods research. Thousand Oaks, 2011.
    48. ↵
      1. Berg KM,
      2. Arnsten JH
      . Practical and conceptual challenges in measuring antiretroviral adherence. J Acquir Immune Defic Syndr 2006;43:S79–87. doi:10.1097/01.qai.0000248337.97814.66
      OpenUrlCrossRefPubMedWeb of Science
    49. ↵
      1. Deane KD,
      2. Parkhurst JO,
      3. Johnston D
      . Linking migration, mobility and HIV. Trop Med Int Health 2010;15:1458–63. doi:10.1111/j.1365-3156.2010.02647.x
      OpenUrlCrossRefPubMed
    50. ↵
      1. Douglas P,
      2. Cetron M,
      3. Spiegel P
      . Definitions matter: migrants, immigrants, asylum seekers and refugees. J Travel Med 2019;26:taz005. doi:10.1093/jtm/taz005
    51. ↵
      1. Baggaley RF,
      2. Nazareth J,
      3. Divall P, et al
      . National policies for delivering tuberculosis, HIV and hepatitis B and C virus infection services for refugees and migrants among Member States of the WHO European Region. J Travel Med 2023;30:taac136. doi:10.1093/jtm/taac136
    52. ↵
    53. ↵
      1. Myers TR,
      2. Lin X,
      3. Skarbinski J
      . Antiretroviral therapy and viral suppression among foreign-born HIV-infected persons receiving medical care in the United States: a complex sample, cross-sectional survey. Medicine (Baltimore) 2016;95:e3051. doi:10.1097/MD.0000000000003051
    54. ↵
      1. Henry J Kaiser Family Fondation
      . Ryan white support and sustained viral suppression among adults with HIV, by insurance coverage, Available: https://www.kff.org/wp-content/uploads/2020/09/9537-Figure-11.png
    55. ↵
      1. Roux P,
      2. Marcellin F,
      3. Ndiaye K, et al
      . Posttraumatic stress disorder as a significant correlate of voluntary antiretroviral treatment interruption in adult HIV-infected patients followed up in French hospitals: data from the ANRS-VESPA2 national survey. J Clin Psychiatry 2018;79:17m11659. doi:10.4088/JCP.17m11659
    56. ↵
      1. Gatey C,
      2. Brun A,
      3. Hamet G, et al
      . Does region of origin influence the timing and outcome of first-line antiretroviral therapy in France? HIV Med 2019;20:175–81. doi:10.1111/hiv.12697
      OpenUrl
    57. ↵
      1. de Monteynard L-A,
      2. Matheron S,
      3. Gilquin J, et al
      . Influence of geographic origin, sex, and HIV transmission group on the outcome of first-line combined antiretroviral therapy in France. AIDS 2016;30:2235–46. doi:10.1097/QAD.0000000000001193
      OpenUrl
    58. ↵
      1. Parisey M,
      2. Louni F,
      3. Bouvet E, et al
      . HIV infection in North African patients. AIDS Res Hum Retroviruses 2019;35:628–33. doi:10.1089/AID.2018.0292
      OpenUrl
    59. ↵
      1. Been SK,
      2. van de Vijver DAMC,
      3. Smit J, et al
      . Feasibility of four interventions to improve treatment adherence in migrants living with HIV in The Netherlands. Diagnostics (Basel) 2020;10:980. doi:10.3390/diagnostics10110980
    60. ↵
      1. Osman W,
      2. Ncube F,
      3. Shaaban K, et al
      . Prevalence, predictors, and economic burden of mental health disorders among asylum seekers, refugees and migrants from African countries: A scoping review. PLoS One 2024;19:e0305495. doi:10.1371/journal.pone.0305495
    61. ↵
      1. Moscrop A,
      2. Ziebland S,
      3. Roberts N, et al
      . A systematic review of reasons for and against asking patients about their socioeconomic contexts. Int J Equity Health 2019;18:112. doi:10.1186/s12939-019-1014-2
    62. ↵
      1. Ross J,
      2. Felsen UR,
      3. Cunningham CO, et al
      . Outcomes along the HIV care continuum among undocumented immigrants in clinical care. AIDS Res Hum Retroviruses 2017;33:1038–44. doi:10.1089/AID.2017.0015
      OpenUrl
    63. ↵
      1. Steel J,
      2. Herlitz C,
      3. Matthews J, et al
      . Pre-migration trauma and HIV-risk behavior. Transcult Psychiatry 2003;40:91–108. doi:10.1177/1363461503040001006
      OpenUrlPubMed
    64. ↵
      1. Miller TA
      . Health literacy and adherence to medical treatment in chronic and acute illness: A meta-analysis. Patient Educ Couns 2016;99:1079–86. doi:10.1016/j.pec.2016.01.020
      OpenUrlCrossRefPubMed
    65. ↵
      1. Perazzo J,
      2. Reyes D,
      3. Webel A
      . A systematic review of health literacy interventions for people living with HIV. AIDS Behav 2017;21:812–21. doi:10.1007/s10461-016-1329-6
      OpenUrlPubMed
    66. ↵
      1. Milz RU,
      2. Husstedt I-W,
      3. Reichelt D, et al
      . Control beliefs and health locus of control in Ugandan, German and migrated sub-Saharan African HIV infected individuals. J Psychosom Res 2016;83:22–6. doi:10.1016/j.jpsychores.2016.02.005
      OpenUrl
    67. ↵
      1. Levison JH,
      2. Levinson JK,
      3. Alegría M
      . A critical review and commentary on the challenges in engaging HIV-infected latinos in the continuum of HIV care. AIDS Behav 2018;22:2500–12. doi:10.1007/s10461-018-2187-1
      OpenUrl
      1. Ridolfo AL,
      2. Oreni L,
      3. Vassalini P, et al
      . Effect of legal status on the early treatment outcomes of migrants beginning combined antiretroviral therapy at an outpatient clinic in Milan, Italy. J Acquir Immune Defic Syndr 2017;75:315–21. doi:10.1097/QAI.0000000000001388
      OpenUrl
      1. Been SK,
      2. van de Vijver DAMC,
      3. Nieuwkerk PT, et al
      . Risk factors for non-adherence to cART in immigrants with HIV living in the Netherlands: results from the ROtterdam ADherence (ROAD) project. PLoS ONE 2016;11:e0162800. doi:10.1371/journal.pone.0162800
      1. Mambet Doue C,
      2. Roussiau N
      . The role of mediators in the indirect effects of religiosity on therapeutic compliance in African migrant HIV-positive patients. J Relig Health 2016;55:1850–63. doi:10.1007/s10943-015-0155-x
      OpenUrl
      1. Herrmann S,
      2. Wardrop J,
      3. John M, et al
      . The impact of visa status and Medicare eligibility on people diagnosed with HIV in Western Australia: a qualitative report. Sex Health 2012;9:407–13. doi:10.1071/SH11181
      OpenUrl
      1. Borchmann O,
      2. Omland LH,
      3. Gerstoft J, et al
      . Length of stay in Denmark before HIV diagnosis and linkage to care: a population-based study of migrants living with HIV, Denmark, 1995 to 2020. Euro Surveill 2022;27:2100809. doi:10.2807/1560-7917.ES.2022.27.30.2100809
      OpenUrl
      1. Vignier N,
      2. Spira RD,
      3. Bouchaud O, et al
      . Refusal to provide health care to sub-Saharan African migrants in France. Lancet Public Health 2018;3:S2468-2667(17)30246-3. doi:10.1016/S2468-2667(17)30246-3

    Footnotes

    • Contributors JGdB is the guarantor. NV, OB, RG and JGdB designed the study. JGdB managed the data collection. Data screening and extraction was performed by JGdB, CP, BV, YK, JZ, BV and NV. JGdB performed the forest plots. JGdB drafted the first versions of the manuscript. NV, OB, LM, HD, RM and NV reviewed the final manuscript. All authors read and approved the final manuscript.

    • Funding ARS Agence Régionale de Santé, Ile de France.

    • Competing interests None declared.

    • Patient and public involvement Patients and/or the public were not involved in the design, or conduct, or reporting, or dissemination plans of this research.

    • Provenance and peer review Not commissioned; externally peer reviewed.

    • Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.